Page 91 - AN-3-1

Advanced Neurology Neurophysiology in hypokinetic disorders

changes from medical and rehabilitative treatments. 36-40 Acknowledgments
Therefore, the use of a combination of cortical evoked
potentials in drug-naïve PD patients after medical None.
treatment could assist movement disorder specialists Funding
and clinicians in better patient management (i.e., taking
into account the positive adaptive cortical changes None.
from applying neurophysiology). In summation, recent Conflict of interest
neurophysiological studies have established a strong
foundation for applying neurophysiology in the field of The author declares that she has no competing interests.
hypokinetic movement disorders, thereby encouraging Author contributions
clinicians to consider this approach in their daily clinical
practice. This is a single-authored article.

5. Conclusion Ethics approval and consent to participate

This review is intended to update clinicians on the recent Not applicable.
advances in neurophysiological examinations for the
characterization of hypokinetic movement disorders Consent for publication
in daily practice. Several strategies (e.g., EMG analyses Not applicable.
in combination with accelerometer, TMS studies,
EEG models, and cortical and brainstem excitability Availability of data
assessments) were proposed to facilitate the diagnosis and Not applicable.
management of hypokinetic movement disorders.
Recent evidence has accentuated the necessity to adopt References
comprehensive neurophysiological diagnostic techniques 1. Fahn S, Jankovic J, editors. Principles and Practice of
to effectively diagnose hypokinetic movement disorders Movement Disorders. USA, Philadelphia, PA: Churchill
(e.g., early PD and APS). Accordingly, neurophysiological Livingstone, Elsevier; 2007. p. 1-652.
markers of neuroplasticity could also predict the efficacy 2. Merchant SH, Vial-Undurraga F, Leodori G, Van Gerpen JA,
of levodopa in early PD, underlining the importance of Hallett M. Myoclonus: An electrophysiological diagnosis.
neurophysiology in PD treatment. Moreover, identifying Mov Disord Clin Pract. 2020;7(5):489-499.
7
the functional features of hypokinetic disorders (e.g., to doi: 10.1002/mdc3.12986
differentiate APSs) facilitates the development of precision 3. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic
medicine and new therapeutic strategies. 36-39 criteria for Parkinson’s disease. Mov Disord. 2015;30:1591-601.

The proposed algorithms could assist clinicians in doi: 10.1002/mds.26424
differentiating hypokinetic movement disorders at an early 4. Postuma RB, Poewe W, Litvan I, et al. Validation of the
stage and also offer the most efficient therapeutic strategies. MDS clinical diagnostic criteria for Parkinson’s disease. Mov
Therefore, neurophysiological techniques should be Disord. 2018;33:1601-1608.
used as diagnostic tests during routine examinations doi: 10.1002/mds.27362
in clinical practice for more informed therapeutic
outcomes. Although clinical neurophysiology is currently 5. Espay AJ, Litvan I. Parkinsonism and frontotemporal
underutilized in neurological practice, as demonstrated dementia: The clinical overlap. J Mol Neurosci. 2011;45:343-9.
by the exiguous number of studies conducted recently, doi: 10.1007/s12031-011-9632-1
it remains an important tool for improving the clinical 6. Apartis E. Clinical neurophysiology in movement disorders.
characterization of movement disorders. Despite of Handb Clin Neurol. 2013;111:87-92.
prospects of neurophysiology in movement disorders, a doi: 10.1016/B978-0-444-52891-9.00008-7
proper neurophysiological examination would require
adequate training and expertise to perform. Movement 7. Sciacca G, Mostile G, Disilvestro I, et al. Long-duration
disorder specialists and clinicians should learn the response to levodopa, motor learning, and neuroplasticity
in early Parkinson’s disease. Mov Disord. 38(4):626-635.
necessary skills to provide a more accurate diagnosis
and more informed treatment of movement disorders, doi: 10.1002/mds.29344
especially for hypokinetic movement diseases. 8. Wilken M, Bruno V, Rossi M, et al. Sensitivity and specificity

Volume 3 Issue 1 (2024) 9 https://doi.org/10.36922/an.1961